• Puma Biotechnology held its annual shareholder meeting on June 11, 2026.
• Shareholders ratified KPMG as independent registered accounting firm for the fiscal year ending Dec. 31, 2026.
• Investors rejected an amendment to extend Alan H. Auerbach’s warrant to buy 2,116,250 shares at $16 per share from Oct. 4, 2026 to Oct. 4, 2028.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Puma Biotechnology Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-26-020793), on June 16, 2026, and is solely responsible for the information contained therein.